Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
PSMA2 | PSMA5 | PSMA5: Proteasome subunit alpha type-5 | 2.34E6 | Evidence | O | ||||
PSMA2 | PSMA3 | PSMA3, PSC8: Proteasome subunit alpha type-3 | 7.81E5 | Evidence | |||||
PSMA2 | PSMA4 | PSMA4, PSC9: Proteasome subunit alpha type-4 | 4.74E5 | Evidence | O | ||||
PSMA2 | PSMA7 | PSMA7: Proteasome subunit alpha type-7 | 3.76E5 | Evidence | |||||
PSMA2 | PSMA6 | PSMA6, PROS27: Proteasome subunit alpha type-6 | 4.48E4 | Evidence | O | ||||
PSMA2 | PLK1 | PLK1, PLK: Serine/threonine-protein kinase PLK1 | 1.58E4 | Evidence | O | ||||
PSMA2 | PSMB7 | PSMB7: Proteasome subunit beta type-7 precursor | 1.38E3 | Evidence | O | ||||
PSMA2 | PSMB2 | PSMB2: Proteasome subunit beta type-2 | 597.0 | Evidence | O | ||||
PSMA2 | PSMB1 | PSMB1, PSC5: Proteasome subunit beta type-1 precursor | 597.0 | Evidence | O | ||||
PSMA2 | PSMA1 | N/A | 411.0 | Evidence | |||||
PSMA2 | CSNK2A1 | CSNK2A1: CSNK2A1 protein | 372.0 | Evidence | |||||
PSMA2 | PSMB6 | PSMB6, LMPY: Proteasome subunit beta type-6 precursor | 280.0 | Evidence | O | ||||
PSMA2 | PSMA8 | PSMA8, PSMA7L: Proteasome subunit alpha type-7-like | 276.0 | Evidence | |||||
PSMA2 | PSMB3 | PSMB3: Proteasome subunit beta type-3 | 169.0 | Evidence | O | ||||
PSMA2 | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 43.00 | Evidence | |||||
PSMA2 | PSMB9 | PSMB9, LMP2, RING12: Proteasome subunit beta type-9 precursor | 27.40 | Evidence | |||||
PSMA2 | MAP2K5 | N/A | 12.70 | Evidence | |||||
PSMA2 | PSMD4 | PSMD4, MCB1: 26S proteasome non-ATPase regulatory subunit 4 | 9.16 | Evidence | |||||
PSMA2 | PSMC2 | PSMC2, MSS1: 26S protease regulatory subunit 7 | 5.17 | Evidence | O | ||||
PSMA2 | PSMC3 | PSMC3, TBP1: 26S protease regulatory subunit 6A | 4.84 | Evidence | O | ||||
PSMA2 | PSMB8 | PSMB8, DAQB-69D7.6-002, DASS-67H14.1-002, XXbac-BCX32M13.6-002, XXbac-BPG246D15. | 4.84 | Evidence | |||||
PSMA2 | PPP2CB | PPP2CB: Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform | 3.77 | Evidence | O | ||||
PSMA2 | PSMB5 | DKFZp686I0180: Putative uncharacterized protein DKFZp686I0180 (Fragment) | 3.01 | Evidence | O | ||||
PSMA2 | NUP98 | N/A | 2.94 | Evidence | |||||
PSMA2 | PPP2CA | PPP2CA: Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform | 2.90 | Evidence | |||||
PSMA2 | FNBP1 | N/A | 2.90 | Evidence | |||||
PSMA2 | KIF3A | KIF3A, KIF3: Kinesin-like protein KIF3A | 2.70 | Evidence | |||||
PSMA2 | PSMD8 | 2.64 | Evidence | O | |||||
PSMA2 | PSMA1 | PSMA1, PROS30, PSC2: Proteasome subunit alpha type-1 | 2.52 | Evidence | |||||
PSMA2 | HSPE1 | HSPE1: 10 kDa heat shock protein, mitochondrial | 1.90 | Evidence | |||||
PSMA2 | HSPA8 | HSPA8, HSC70, HSP73, HSPA10: Heat shock cognate 71 kDa protein | 1.71 | Evidence | |||||
PSMA2 | PSMB4 | N/A | 1.57 | Evidence | O | ||||
PSMA2 | RANBP5 | 1.57 | Evidence | O | |||||
PSMA2 | NULL | RcPSMB3 (Fragment) | 1.18 | Evidence | |||||
PSMA2 | MAPK6 | MAPK6, ERK3, PRKM6: Mitogen-activated protein kinase 6 | 0.738 | Evidence | |||||
PSMA2 | THUMPD1 | N/A | 0.667 | Evidence | |||||
PSMA2 | OXSR1 | OXSR1, KIAA1101, OSR1: Serine/threonine-protein kinase OSR1 | 0.66 | Evidence | |||||
PSMA2 | STK24 | STK24, MST3, STK3: Serine/threonine-protein kinase 24 | 0.66 | Evidence | |||||
PSMA2 | CDK4 | CDK4: Cell division protein kinase 4 | 0.66 | Evidence | |||||
PSMA2 | CDK7 | CDK7, MO15: Cell division protein kinase 7 | 0.66 | Evidence | |||||
PSMA2 | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 0.61 | Evidence | |||||
PSMA2 | PSME4 | PSME4, KIAA0077: Proteasome activator complex subunit 4 | 0.593 | Evidence | |||||
PSMA2 | CTRL | PSMB10, MECL1: Proteasome subunit beta type-10 precursor | 0.575 | Evidence | O | ||||
PSMA2 | VAC14 | VAC14, TAX1BP2, TRX: Protein VAC14 homolog | 0.537 | Evidence | O | ||||
PSMA2 | PSMB4 | PSMB4: Proteasome subunit beta type-4 precursor | 0.535 | Evidence | O | ||||
PSMA2 | PLK4 | PLK4, SAK, STK18: Serine/threonine-protein kinase PLK4 | 0.515 | Evidence | |||||
PSMA2 | VPS13A | 0.512 | Evidence | ||||||
PSMA2 | TRIP10 | TRIP10, CIP4, STOT, STP: Cdc42-interacting protein 4 | 0.512 | Evidence | |||||
PSMA2 | MAP4K1 | MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 | 0.445 | Evidence | |||||
PSMA2 | IRAK1 | IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 | 0.4 | Evidence | |||||
PSMA2 | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 0.4 | Evidence | |||||
PSMA2 | CDK2 | CDK2: Cell division protein kinase 2 | 0.4 | Evidence | |||||
PSMA2 | CHEK1 | CHEK1, CHK1: Serine/threonine-protein kinase Chk1 | 0.4 | Evidence | |||||
PSMA2 | EIF2S2 | EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 | 0.367 | Evidence | |||||
PSMA2 | ROCK1 | ROCK1: Rho-associated protein kinase 1 | 0.36 | Evidence | |||||
PSMA2 | GORASP2 | N/A | 0.36 | Evidence | |||||
PSMA2 | PRKCI | PRKCI, DXS1179E: Protein kinase C iota type | 0.323 | Evidence | |||||
PSMA2 | PKMYT1 | PKMYT1, MYT1: Membrane-associated tyrosine- and threonine-specific cdc2-inhibito | 0.323 | Evidence | |||||
PSMA2 | CDC7 | CDC7, CDC7L1: Cell division cycle 7-related protein kinase | 0.323 | Evidence | |||||
PSMA2 | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 0.323 | Evidence | |||||
PSMA2 | RPS6KB1 | N/A | 0.323 | Evidence | |||||
PSMA2 | PRPF4B | PRPF4B, KIAA0536, PRP4, PRP4H, PRP4K: Serine/threonine-protein kinase PRP4 homol | 0.323 | Evidence | |||||
PSMA2 | AURKA | AURKA, AIK, ARK1, AURA, BTAK, STK15, STK6: Serine/threonine-protein kinase 6 | 0.323 | Evidence | |||||
PSMA2 | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 0.323 | Evidence | |||||
PSMA2 | PBK | PBK, TOPK: Lymphokine-activated killer T-cell-originated protein kinase | 0.323 | Evidence | |||||
PSMA2 | VRK1 | VRK1: Serine/threonine-protein kinase VRK1 | 0.323 | Evidence | |||||
PSMA2 | WEE1 | WEE1: Wee1-like protein kinase | 0.323 | Evidence | |||||
PSMA2 | MAP2K1 | MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 | 0.323 | Evidence | |||||
PSMA2 | PRKDC | PRKDC, HYRC, HYRC1: DNA-dependent protein kinase catalytic subunit | 0.265 | Evidence | |||||
PSMA2 | STK16 | N/A | 0.265 | Evidence | |||||
PSMA2 | NEK9 | NEK9, KIAA1995, NEK8, NERCC: Serine/threonine-protein kinase Nek9 | 0.263 | Evidence | |||||
PSMA2 | NUP54 | NUP54: Nucleoporin p54 | 0.26 | Evidence | |||||
PSMA2 | RAN | RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran | 0.237 | Evidence | |||||
PSMA2 | CARS | CARS: Cysteinyl-tRNA synthetase, cytoplasmic | 0.237 | Evidence | |||||
PSMA2 | NME2 | NME2, NM23B: Nucleoside diphosphate kinase B | 0.237 | Evidence | |||||
PSMA2 | CCT8 | CCT8: Uncharacterized protein CCT8 | 0.237 | Evidence | |||||
PSMA2 | EPRS | EPRS, GLNS, PARS, QARS, QPRS: Bifunctional aminoacyl-tRNA synthetase [Includes: | 0.237 | Evidence | |||||
PSMA2 | MAPRE1 | MAPRE1: Microtubule-associated protein RP/EB family member 1 | 0.237 | Evidence | |||||
PSMA2 | ILK | ILK, ILK1, ILK2: Integrin-linked protein kinase | 0.237 | Evidence | |||||
PSMA2 | PRKD2 | PRKD2, PKD2, HSPC187: Serine/threonine-protein kinase D2 | 0.237 | Evidence | |||||
PSMA2 | AKT1 | AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase | 0.237 | Evidence | |||||
PSMA2 | SCYL3 | SCYL3, PACE1: Protein-associating with the carboxyl-terminal domain of ezrin | 0.237 | Evidence | |||||
PSMA2 | TAOK3 | TAOK3, DPK, JIK, KDS, MAP3K18: Serine/threonine-protein kinase TAO3 | 0.237 | Evidence | |||||
PSMA2 | PKN2 | PKN2, PRK2, PRKCL2: Serine/threonine-protein kinase N2 | 0.237 | Evidence | |||||
PSMA2 | CRKRS | CRKRS, CRK7, KIAA0904: Cell division cycle 2-related protein kinase 7 | 0.237 | Evidence | |||||
PSMA2 | ADRBK1 | ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 | 0.237 | Evidence | |||||
PSMA2 | STK3 | STK3, MST2: Serine/threonine-protein kinase 3 | 0.237 | Evidence | |||||
PSMA2 | PSMB5 | PSMB5, LMPX: Proteasome subunit beta type-5 precursor | 0.23 | Evidence | |||||
PSMA2 | CCNB2 | CCNB2: G2/mitotic-specific cyclin-B2 | 0.223 | Evidence | |||||
PSMA2 | MAPKAPK2 | MAPKAPK2: MAP kinase-activated protein kinase 2 | 0.217 | Evidence | |||||
PSMA2 | CSK | CSK: Tyrosine-protein kinase CSK | 0.203 | Evidence | |||||
PSMA2 | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 0.203 | Evidence | |||||
PSMA2 | BRAF | BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase | 0.195 | Evidence | |||||
PSMA2 | STK38 | STK38, NDR1: Serine/threonine-protein kinase 38 | 0.195 | Evidence | |||||
PSMA2 | NEK7 | NEK7: Serine/threonine-protein kinase Nek7 | 0.195 | Evidence | |||||
PSMA2 | STK10 | STK10: Uncharacterized protein STK10 | 0.195 | Evidence | |||||
PSMA2 | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 0.195 | Evidence | |||||
PSMA2 | CSNK1E | CSNK1E: Casein kinase I isoform epsilon | 0.195 | Evidence | |||||
PSMA2 | MAPK13 | MAPK13, PRKM13, SAPK4: Mitogen-activated protein kinase 13 | 0.195 | Evidence | |||||
PSMA2 | RPS6KB2 | RPS6KB2, STK14B: Ribosomal protein S6 kinase beta-2 | 0.195 | Evidence | |||||
PSMA2 | MAPK12 | MAPK12, ERK6, SAPK3: Mitogen-activated protein kinase 12 | 0.195 | Evidence | |||||
PSMA2 | PLK3 | PLK3, CNK, FNK, PRK: Serine/threonine-protein kinase PLK3 | 0.195 | Evidence | |||||
PSMA2 | KIAA0368 | ECM29, KIAA0368: Proteasome-associated protein ECM29 homolog | 0.19 | Evidence | |||||
PSMA2 | PLK2 | PLK2, SNK: Serine/threonine-protein kinase PLK2 | 0.18 | Evidence | |||||
PSMA2 | LOC391276 | N/A | 0.165 | Evidence | |||||
PSMA2 | MAP3K8 | MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 | 0.165 | Evidence | |||||
PSMA2 | IKBKB | IKBKB, IKKB: Inhibitor of nuclear factor kappa-B kinase subunit beta | 0.165 | Evidence | |||||
PSMA2 | MAP3K5 | MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 | 0.165 | Evidence | |||||
PSMA2 | RIPK1 | RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 | 0.165 | Evidence | |||||
PSMA2 | PASK | PASK, KIAA0135: PAS domain-containing serine/threonine-protein kinase | 0.165 | Evidence | |||||
PSMA2 | NEK1 | NEK1, KIAA1901: Serine/threonine-protein kinase Nek1 | 0.165 | Evidence | |||||
PSMA2 | TBK1 | TBK1, NAK: Serine/threonine-protein kinase TBK1 | 0.163 | Evidence | |||||
PSMA2 | STK4 | STK4, MST1: Serine/threonine-protein kinase 4 | 0.147 | Evidence | |||||
PSMA2 | MAPKAPK3 | MAPKAPK3: MAP kinase-activated protein kinase 3 | 0.147 | Evidence | |||||
PSMA2 | PCTK1 | PCTK1: Serine/threonine-protein kinase PCTAIRE-1 | 0.147 | Evidence | |||||
PSMA2 | STK11 | STK11, LKB1, PJS: Serine/threonine-protein kinase 11 | 0.147 | Evidence | |||||
PSMA2 | PRKR | EIF2AK2, PKR, PRKR: Interferon-induced, double-stranded RNA-activated protein ki | 0.142 | Evidence | |||||
PSMA2 | MAPK15 | N/A | 0.142 | Evidence | |||||
PSMA2 | CDC2L1 | CDC2L1, PITSLREA, PK58: PITSLRE serine/threonine-protein kinase CDC2L1 | 0.142 | Evidence | |||||
PSMA2 | MAPK10 | MAPK10, JNK3, JNK3A, PRKM10: Mitogen-activated protein kinase 10 | 0.142 | Evidence | |||||
PSMA2 | PKN1 | PKN1, PKN, PRK1, PRKCL1: Serine/threonine-protein kinase N1 | 0.142 | Evidence | |||||
PSMA2 | CDC2L2 | CDC2L2, CDC2L3, PITSLREB: PITSLRE serine/threonine-protein kinase CDC2L2 | 0.142 | Evidence | |||||
PSMA2 | MAPK8 | MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 | 0.142 | Evidence | |||||
PSMA2 | MAPKAPK5 | N/A | 0.142 | Evidence | |||||
PSMA2 | MAPK9 | MAPK9, JNK2, PRKM9: Mitogen-activated protein kinase 9 | 0.142 | Evidence | |||||
PSMA2 | MINK1 | MAP4K6, MINK1, MINK: Misshapen-like kinase 1 | 0.142 | Evidence | |||||
PSMA2 | DYRK1A | DYRK1A, DYRK, MNB, MNBH: Dual specificity tyrosine-phosphorylation-regulated kin | 0.142 | Evidence | |||||
PSMA2 | HMGN1 | HMGN1, HMG14: Non-histone chromosomal protein HMG-14 | 0.138 | Evidence | |||||
PSMA2 | SET | SET: Protein SET | 0.138 | Evidence | |||||
PSMA2 | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 0.135 | Evidence | |||||
PSMA2 | MAP3K14 | MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 | 0.133 | Evidence | |||||
PSMA2 | SRPK2 | SRPK2: Serine/threonine-protein kinase SRPK2 | 0.133 | Evidence | |||||
PSMA2 | PRKAA1 | N/A | 0.133 | Evidence | |||||
PSMA2 | MAPK4 | MAPK4, ERK4, PRKM4: Mitogen-activated protein kinase 4 | 0.133 | Evidence | |||||
PSMA2 | CDC2L5 | CDC2L5, CDC2L, CHED, KIAA1791: Cell division cycle 2-like protein kinase 5 | 0.128 | Evidence | |||||
PSMA2 | LATS2 | LATS2, KPM: Serine/threonine-protein kinase LATS2 | 0.128 | Evidence | |||||
PSMA2 | MAP3K7 | MAP3K7, TAK1: Mitogen-activated protein kinase kinase kinase 7 | 0.128 | Evidence | |||||
PSMA2 | RPS6KA4 | RPS6KA4, MSK2: Ribosomal protein S6 kinase alpha-4 | 0.128 | Evidence | |||||
PSMA2 | CAMK1D | CAMK1D: Calcium/calmodulin-dependent protein kinase type 1D | 0.128 | Evidence | |||||
PSMA2 | CDC2 | CDC2: Cell division control protein 2 homolog | 0.128 | Evidence | |||||
PSMA2 | AKT3 | AKT3: RAC-gamma serine/threonine-protein kinase | 0.128 | Evidence | |||||
PSMA2 | RPS6KA2 | RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 | 0.128 | Evidence | |||||
PSMA2 | CAMK4 | CAMK4: Calcium/calmodulin-dependent protein kinase type IV | 0.128 | Evidence | |||||
PSMA2 | DYRK1B | DYRK1B, MIRK: Dual specificity tyrosine-phosphorylation-regulated kinase 1B | 0.128 | Evidence | |||||
PSMA2 | PRKACA | PRKACA, PKACA: cAMP-dependent protein kinase, alpha-catalytic subunit | 0.128 | Evidence | |||||
PSMA2 | MKNK2 | MKNK2, GPRK7, MNK2: MAP kinase-interacting serine/threonine-protein kinase 2 | 0.128 | Evidence | |||||
PSMA2 | PHKG1 | PHKG1, PHKG: Phosphorylase b kinase gamma catalytic chain, skeletal muscle isofo | 0.128 | Evidence | |||||
PSMA2 | NEK6 | NEK6: Serine/threonine-protein kinase Nek6 | 0.128 | Evidence | |||||
PSMA2 | SGK2 | SGK2: Serine/threonine-protein kinase Sgk2 | 0.128 | Evidence | |||||
PSMA2 | PDPK1 | PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 | 0.128 | Evidence | |||||
PSMA2 | MKNK1 | MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 | 0.128 | Evidence | |||||
PSMA2 | LATS1 | LATS1, WARTS: Serine/threonine-protein kinase LATS1 | 0.128 | Evidence | |||||
PSMA2 | NSF | NSF: Vesicle-fusing ATPase | 0.128 | Evidence | O | ||||
PSMA2 | CCT4 | CCT4, CCTD, SRB: T-complex protein 1 subunit delta | 0.125 | Evidence |